APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bipolar Disorder Mood Stabilizers

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bipolar Disorder Mood Stabilizers Industry Growth and Trends Forecast to 2032

23 December 2025123 pages

Choose your research edition.

Industry ResearchBipolar Disorder Mood Stabilizers Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Bipolar Disorder Mood Stabilizers Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Bipolar Disorder Mood Stabilizers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bipolar Disorder Mood Stabilizers Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Bipolar Disorder Mood Stabilizers Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Bipolar Disorder Mood Stabilizers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bipolar Disorder Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bipolar Disorder Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bipolar Disorder Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bipolar Disorder Mood Stabilizers include Teva Pharmaceuticals, CSPC Pharmaceutical Group, Sanofi, Johnson And Johnson, Qilu Pharmaceutical, Novartis, Luye Pharma Group, Eli Lilly and Kanghong Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bipolar Disorder Mood Stabilizers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bipolar Disorder Mood Stabilizers market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bipolar Disorder Mood Stabilizers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bipolar Disorder Mood Stabilizers.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bipolar Disorder Mood Stabilizers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bipolar Disorder Mood Stabilizers Market by Company

Teva Pharmaceuticals

CSPC Pharmaceutical Group

Sanofi

Johnson And Johnson

Qilu Pharmaceutical

Novartis

Luye Pharma Group

Eli Lilly

Kanghong Pharmaceutical

Nhwa Pharmaceutical

Pfizer

Huahai Pharmaceutical

Hengrui Pharmaceuticals

Glaxo Smith Kline

Dongting Pharmaceutical

Sihuan Pharma

AstraZeneca

Otsuka Pharmaceutical

Lundbeck

Glenmark Pharmaceuticals

Bipolar Disorder Mood Stabilizers Segment by Type

Lithium Salt Drugs

Antiepileptic Drugs

Atypical Antipsychotics

Bipolar Disorder Mood Stabilizers Segment by Application

Manic Episode

Depressive Episode

Maintenance Treatment

Bipolar Disorder Mood Stabilizers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bipolar Disorder Mood Stabilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bipolar Disorder Mood Stabilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bipolar Disorder Mood Stabilizers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bipolar Disorder Mood Stabilizers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bipolar Disorder Mood Stabilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lithium Salt Drugs Table 2. Major Company of Antiepileptic Drugs Table 3. Major Company of Atypical Antipsychotics Table 4. Global Bipolar Disorder Mood Stabilizers Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (units) Table 6. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Type (2021-2026) Table 7. Global Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 8. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Type (2021-2026) Table 9. Global Bipolar Disorder Mood Stabilizers Price by Type (2021-2026) & (USD/unit) Table 10. Global Bipolar Disorder Mood Stabilizers Sales by Type (2027-2032) & (units) Table 11. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Type (2027-2032) Table 12. Global Bipolar Disorder Mood Stabilizers Sales by Type (2027-2032) & (US$ Million) Table 13. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Type (2027-2032) Table 14. Global Bipolar Disorder Mood Stabilizers Price by Type (2027-2032) & (USD/unit) Table 15. North America Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (units) Table 16. North America Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (units) Table 18. Europe Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (units) Table 20. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (units) Table 22. Latin America Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (units) Table 24. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 25. Bipolar Disorder Mood Stabilizers Industry Trends Table 26. Bipolar Disorder Mood Stabilizers Industry Drivers Table 27. Bipolar Disorder Mood Stabilizers Industry Opportunities and Challenges Table 28. Bipolar Disorder Mood Stabilizers Industry Restraints Table 29. Global Bipolar Disorder Mood Stabilizers Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Bipolar Disorder Mood Stabilizers Revenue Market Share by Company (2021-2026) Table 31. Global Bipolar Disorder Mood Stabilizers Sales by Company (2021-2026) & (units) Table 32. Global Bipolar Disorder Mood Stabilizers Sales Share by Company (2021-2026) Table 33. Global Bipolar Disorder Mood Stabilizers Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Bipolar Disorder Mood Stabilizers Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Bipolar Disorder Mood Stabilizers Major Company Production Sites and Headquarters Table 36. Global Bipolar Disorder Mood Stabilizers Company, Product Type & Application Table 37. Global Bipolar Disorder Mood Stabilizers Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Bipolar Disorder Mood Stabilizers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Bipolar Disorder Mood Stabilizers Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Bipolar Disorder Mood Stabilizers Sales by Region (2021-2026) & (units) Table 42. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Region (2021-2026) Table 43. Global Bipolar Disorder Mood Stabilizers Sales by Region (2021-2026) & (US$ Million) Table 44. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Region (2021-2026) Table 45. Global Bipolar Disorder Mood Stabilizers Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Bipolar Disorder Mood Stabilizers Sales by Region (2027-2032) & (units) Table 47. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Region (2027-2032) Table 48. Global Bipolar Disorder Mood Stabilizers Sales by Region (2027-2032) & (US$ Million) Table 49. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Region (2027-2032) Table 50. Global Bipolar Disorder Mood Stabilizers Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Bipolar Disorder Mood Stabilizers Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (units) Table 53. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Application (2021-2026) Table 54. Global Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 55. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Application (2021-2026) Table 56. Global Bipolar Disorder Mood Stabilizers Price by Application (2021-2026) & (USD/unit) Table 57. Global Bipolar Disorder Mood Stabilizers Sales by Application (2027-2032) & (units) Table 58. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Application (2027-2032) Table 59. Global Bipolar Disorder Mood Stabilizers Sales by Application (2027-2032) & (US$ Million) Table 60. Global Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Application (2027-2032) Table 61. Global Bipolar Disorder Mood Stabilizers Price by Application (2027-2032) & (USD/unit) Table 62. North America Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (units) Table 63. North America Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (units) Table 65. Europe Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (units) Table 67. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (units) Table 69. Latin America Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (units) Table 71. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceuticals Company Information Table 73. Teva Pharmaceuticals Business Overview Table 74. Teva Pharmaceuticals Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Teva Pharmaceuticals Bipolar Disorder Mood Stabilizers Product Portfolio Table 76. Teva Pharmaceuticals Recent Development Table 77. CSPC Pharmaceutical Group Company Information Table 78. CSPC Pharmaceutical Group Business Overview Table 79. CSPC Pharmaceutical Group Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. CSPC Pharmaceutical Group Bipolar Disorder Mood Stabilizers Product Portfolio Table 81. CSPC Pharmaceutical Group Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Sanofi Bipolar Disorder Mood Stabilizers Product Portfolio Table 86. Sanofi Recent Development Table 87. Johnson And Johnson Company Information Table 88. Johnson And Johnson Business Overview Table 89. Johnson And Johnson Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Johnson And Johnson Bipolar Disorder Mood Stabilizers Product Portfolio Table 91. Johnson And Johnson Recent Development Table 92. Qilu Pharmaceutical Company Information Table 93. Qilu Pharmaceutical Business Overview Table 94. Qilu Pharmaceutical Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Qilu Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio Table 96. Qilu Pharmaceutical Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Novartis Bipolar Disorder Mood Stabilizers Product Portfolio Table 101. Novartis Recent Development Table 102. Luye Pharma Group Company Information Table 103. Luye Pharma Group Business Overview Table 104. Luye Pharma Group Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Luye Pharma Group Bipolar Disorder Mood Stabilizers Product Portfolio Table 106. Luye Pharma Group Recent Development Table 107. Eli Lilly Company Information Table 108. Eli Lilly Business Overview Table 109. Eli Lilly Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Eli Lilly Bipolar Disorder Mood Stabilizers Product Portfolio Table 111. Eli Lilly Recent Development Table 112. Kanghong Pharmaceutical Company Information Table 113. Kanghong Pharmaceutical Business Overview Table 114. Kanghong Pharmaceutical Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Kanghong Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio Table 116. Kanghong Pharmaceutical Recent Development Table 117. Nhwa Pharmaceutical Company Information Table 118. Nhwa Pharmaceutical Business Overview Table 119. Nhwa Pharmaceutical Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Nhwa Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio Table 121. Nhwa Pharmaceutical Recent Development Table 122. Pfizer Company Information Table 123. Pfizer Business Overview Table 124. Pfizer Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Pfizer Bipolar Disorder Mood Stabilizers Product Portfolio Table 126. Pfizer Recent Development Table 127. Huahai Pharmaceutical Company Information Table 128. Huahai Pharmaceutical Business Overview Table 129. Huahai Pharmaceutical Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Huahai Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio Table 131. Huahai Pharmaceutical Recent Development Table 132. Hengrui Pharmaceuticals Company Information Table 133. Hengrui Pharmaceuticals Business Overview Table 134. Hengrui Pharmaceuticals Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Hengrui Pharmaceuticals Bipolar Disorder Mood Stabilizers Product Portfolio Table 136. Hengrui Pharmaceuticals Recent Development Table 137. Glaxo Smith Kline Company Information Table 138. Glaxo Smith Kline Business Overview Table 139. Glaxo Smith Kline Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Glaxo Smith Kline Bipolar Disorder Mood Stabilizers Product Portfolio Table 141. Glaxo Smith Kline Recent Development Table 142. Dongting Pharmaceutical Company Information Table 143. Dongting Pharmaceutical Business Overview Table 144. Dongting Pharmaceutical Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Dongting Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio Table 146. Dongting Pharmaceutical Recent Development Table 147. Sihuan Pharma Company Information Table 148. Sihuan Pharma Business Overview Table 149. Sihuan Pharma Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Sihuan Pharma Bipolar Disorder Mood Stabilizers Product Portfolio Table 151. Sihuan Pharma Recent Development Table 152. AstraZeneca Company Information Table 153. AstraZeneca Business Overview Table 154. AstraZeneca Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. AstraZeneca Bipolar Disorder Mood Stabilizers Product Portfolio Table 156. AstraZeneca Recent Development Table 157. Otsuka Pharmaceutical Company Information Table 158. Otsuka Pharmaceutical Business Overview Table 159. Otsuka Pharmaceutical Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Otsuka Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio Table 161. Otsuka Pharmaceutical Recent Development Table 162. Lundbeck Company Information Table 163. Lundbeck Business Overview Table 164. Lundbeck Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Lundbeck Bipolar Disorder Mood Stabilizers Product Portfolio Table 166. Lundbeck Recent Development Table 167. Glenmark Pharmaceuticals Company Information Table 168. Glenmark Pharmaceuticals Business Overview Table 169. Glenmark Pharmaceuticals Bipolar Disorder Mood Stabilizers Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Glenmark Pharmaceuticals Bipolar Disorder Mood Stabilizers Product Portfolio Table 171. Glenmark Pharmaceuticals Recent Development Table 172. North America Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 173. North America Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026) & (units) Table 174. North America Bipolar Disorder Mood Stabilizers Sales Market Share by Country (2021-2026) Table 175. North America Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032) & (units) Table 176. North America Bipolar Disorder Mood Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 177. North America Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. North America Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 179. North America Bipolar Disorder Mood Stabilizers Market Share by Country (2021-2026) Table 180. North America Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. North America Bipolar Disorder Mood Stabilizers Market Share Forecast by Country (2027-2032) Table 182. Europe Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 183. Europe Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026) & (units) Table 184. Europe Bipolar Disorder Mood Stabilizers Sales Market Share by Country (2021-2026) Table 185. Europe Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032) & (units) Table 186. Europe Bipolar Disorder Mood Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 187. Europe Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Europe Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 189. Europe Bipolar Disorder Mood Stabilizers Market Share by Country (2021-2026) Table 190. Europe Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Europe Bipolar Disorder Mood Stabilizers Market Share Forecast by Country (2027-2032) Table 192. Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 193. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026) & (units) Table 194. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Market Share by Country (2021-2026) Table 195. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032) & (units) Table 196. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 197. Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 199. Asia-Pacific Bipolar Disorder Mood Stabilizers Market Share by Country (2021-2026) Table 200. Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Asia-Pacific Bipolar Disorder Mood Stabilizers Market Share Forecast by Country (2027-2032) Table 202. Latin America Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 203. Latin America Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026) & (units) Table 204. Latin America Bipolar Disorder Mood Stabilizers Sales Market Share by Country (2021-2026) Table 205. Latin America Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032) & (units) Table 206. Latin America Bipolar Disorder Mood Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 207. Latin America Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Latin America Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 209. Latin America Bipolar Disorder Mood Stabilizers Market Share by Country (2021-2026) Table 210. Latin America Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Latin America Bipolar Disorder Mood Stabilizers Market Share Forecast by Country (2027-2032) Table 212. Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 213. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026) & (units) Table 214. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Market Share by Country (2021-2026) Table 215. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032) & (units) Table 216. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 217. Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 218. Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 219. Middle East and Africa Bipolar Disorder Mood Stabilizers Market Share by Country (2021-2026) Table 220. Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 221. Middle East and Africa Bipolar Disorder Mood Stabilizers Market Share Forecast by Country (2027-2032) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Bipolar Disorder Mood Stabilizers Distributors List Table 225. Bipolar Disorder Mood Stabilizers Customers List Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Bipolar Disorder Mood Stabilizers Image Figure 2. Global Bipolar Disorder Mood Stabilizers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bipolar Disorder Mood Stabilizers Market Size (2021-2032) & (US$ Million) Figure 4. Global Bipolar Disorder Mood Stabilizers Sales (2021-2032) & (units) Figure 5. Lithium Salt Drugs Image Figure 6. Global Lithium Salt Drugs Sales YoY Growth (2021-2032) & (units) Figure 7. Antiepileptic Drugs Image Figure 8. Global Antiepileptic Drugs Sales YoY Growth (2021-2032) & (units) Figure 9. Atypical Antipsychotics Image Figure 10. Global Atypical Antipsychotics Sales YoY Growth (2021-2032) & (units) Figure 11. Global Bipolar Disorder Mood Stabilizers Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Bipolar Disorder Mood Stabilizers Market Share by Type 2025 VS 2032 Figure 13. North America Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Type in 2025 Figure 14. North America Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Type in 2025 Figure 15. Europe Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Type in 2025 Figure 16. Europe Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Type in 2025 Figure 19. Latin America Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Bipolar Disorder Mood Stabilizers Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Manic Episode Image Figure 26. Global Manic Episode Sales YoY Growth (2021-2032) & (units) Figure 27. Depressive Episode Image Figure 28. Global Depressive Episode Sales YoY Growth (2021-2032) & (units) Figure 29. Maintenance Treatment Image Figure 30. Global Maintenance Treatment Sales YoY Growth (2021-2032) & (units) Figure 31. Global Bipolar Disorder Mood Stabilizers Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Bipolar Disorder Mood Stabilizers Market Share by Application 2025 VS 2032 Figure 33. North America Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Application in 2025 Figure 34. North America Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Application in 2025 Figure 35. Europe Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Application in 2025 Figure 36. Europe Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Application in 2025 Figure 39. Latin America Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Market Share in Value by Application in 2025 Figure 43. North America Bipolar Disorder Mood Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. North America Bipolar Disorder Mood Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Bipolar Disorder Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Bipolar Disorder Mood Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Bipolar Disorder Mood Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Europe Bipolar Disorder Mood Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bipolar Disorder Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Bipolar Disorder Mood Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Bipolar Disorder Mood Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bipolar Disorder Mood Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Latin America Bipolar Disorder Mood Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Bipolar Disorder Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Bipolar Disorder Mood Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 60. Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Bipolar Disorder Mood Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Bipolar Disorder Mood Stabilizers Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Bipolar Disorder Mood Stabilizers Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Lithium Salt Drugs
  • Antiepileptic Drugs
  • Atypical Antipsychotics
Applications
  • Manic Episode
  • Depressive Episode
  • Maintenance Treatment
Companies covered
  • Teva Pharmaceuticals
  • CSPC Pharmaceutical Group
  • Sanofi
  • Johnson And Johnson
  • Qilu Pharmaceutical
  • Novartis
  • Luye Pharma Group
  • Eli Lilly
  • Kanghong Pharmaceutical
  • Nhwa Pharmaceutical
  • Pfizer
  • Huahai Pharmaceutical
  • Hengrui Pharmaceuticals
  • Glaxo Smith Kline
  • Dongting Pharmaceutical
  • Sihuan Pharma
  • AstraZeneca
  • Otsuka Pharmaceutical
  • Lundbeck
  • Glenmark Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bipolar Disorder Mood Stabilizers Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bipolar Disorder Mood Stabilizers Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bipolar Disorder Mood Stabilizers Market by Type
  6. 1.3.1 Lithium Salt Drugs
  7. 1.3.2 Antiepileptic Drugs
  8. 1.3.3 Atypical Antipsychotics
  9. 1.4 Global Bipolar Disorder Mood Stabilizers Market Size by Type
  10. 1.4.1 Global Bipolar Disorder Mood Stabilizers Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Bipolar Disorder Mood Stabilizers Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Bipolar Disorder Mood Stabilizers Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Bipolar Disorder Mood Stabilizers Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Bipolar Disorder Mood Stabilizers Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Bipolar Disorder Mood Stabilizers Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bipolar Disorder Mood Stabilizers Industry Trends
  2. 2.2 Bipolar Disorder Mood Stabilizers Industry Drivers
  3. 2.3 Bipolar Disorder Mood Stabilizers Industry Opportunities and Challenges
  4. 2.4 Bipolar Disorder Mood Stabilizers Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bipolar Disorder Mood Stabilizers Revenue (2021-2026)
  2. 3.2 Global Top Players by Bipolar Disorder Mood Stabilizers Sales (2021-2026)
  3. 3.3 Global Top Players by Bipolar Disorder Mood Stabilizers Price (2021-2026)
  4. 3.4 Global Bipolar Disorder Mood Stabilizers Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bipolar Disorder Mood Stabilizers Major Company Production Sites & Headquarters
  6. 3.6 Global Bipolar Disorder Mood Stabilizers Company, Product Type & Application
  7. 3.7 Global Bipolar Disorder Mood Stabilizers Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bipolar Disorder Mood Stabilizers Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bipolar Disorder Mood Stabilizers Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bipolar Disorder Mood Stabilizers Tier 1, Tier 2, and Tier 3
4 Bipolar Disorder Mood Stabilizers Regional Status and Outlook
  1. 4.1 Global Bipolar Disorder Mood Stabilizers Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bipolar Disorder Mood Stabilizers Historic Market Size by Region
  3. 4.2.1 Global Bipolar Disorder Mood Stabilizers Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bipolar Disorder Mood Stabilizers Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bipolar Disorder Mood Stabilizers Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bipolar Disorder Mood Stabilizers Forecasted Market Size by Region
  7. 4.3.1 Global Bipolar Disorder Mood Stabilizers Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bipolar Disorder Mood Stabilizers Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bipolar Disorder Mood Stabilizers Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bipolar Disorder Mood Stabilizers by Application
  1. 5.1 Bipolar Disorder Mood Stabilizers Market by Application
  2. 5.1.1 Manic Episode
  3. 5.1.2 Depressive Episode
  4. 5.1.3 Maintenance Treatment
  5. 5.2 Global Bipolar Disorder Mood Stabilizers Market Size by Application
  6. 5.2.1 Global Bipolar Disorder Mood Stabilizers Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Bipolar Disorder Mood Stabilizers Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Bipolar Disorder Mood Stabilizers Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Bipolar Disorder Mood Stabilizers Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Bipolar Disorder Mood Stabilizers Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Bipolar Disorder Mood Stabilizers Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals
  2. 6.1.1 Teva Pharmaceuticals Company Information
  3. 6.1.2 Teva Pharmaceuticals Business Overview
  4. 6.1.3 Teva Pharmaceuticals Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Bipolar Disorder Mood Stabilizers Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Recent Developments
  7. 6.2 CSPC Pharmaceutical Group
  8. 6.2.1 CSPC Pharmaceutical Group Company Information
  9. 6.2.2 CSPC Pharmaceutical Group Business Overview
  10. 6.2.3 CSPC Pharmaceutical Group Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Pharmaceutical Group Bipolar Disorder Mood Stabilizers Product Portfolio
  12. 6.2.5 CSPC Pharmaceutical Group Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Bipolar Disorder Mood Stabilizers Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson And Johnson
  20. 6.4.1 Johnson And Johnson Company Information
  21. 6.4.2 Johnson And Johnson Business Overview
  22. 6.4.3 Johnson And Johnson Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson And Johnson Bipolar Disorder Mood Stabilizers Product Portfolio
  24. 6.4.5 Johnson And Johnson Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Bipolar Disorder Mood Stabilizers Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Luye Pharma Group
  38. 6.7.1 Luye Pharma Group Company Information
  39. 6.7.2 Luye Pharma Group Business Overview
  40. 6.7.3 Luye Pharma Group Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Luye Pharma Group Bipolar Disorder Mood Stabilizers Product Portfolio
  42. 6.7.5 Luye Pharma Group Recent Developments
  43. 6.8 Eli Lilly
  44. 6.8.1 Eli Lilly Company Information
  45. 6.8.2 Eli Lilly Business Overview
  46. 6.8.3 Eli Lilly Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli Lilly Bipolar Disorder Mood Stabilizers Product Portfolio
  48. 6.8.5 Eli Lilly Recent Developments
  49. 6.9 Kanghong Pharmaceutical
  50. 6.9.1 Kanghong Pharmaceutical Company Information
  51. 6.9.2 Kanghong Pharmaceutical Business Overview
  52. 6.9.3 Kanghong Pharmaceutical Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Kanghong Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio
  54. 6.9.5 Kanghong Pharmaceutical Recent Developments
  55. 6.10 Nhwa Pharmaceutical
  56. 6.10.1 Nhwa Pharmaceutical Company Information
  57. 6.10.2 Nhwa Pharmaceutical Business Overview
  58. 6.10.3 Nhwa Pharmaceutical Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nhwa Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio
  60. 6.10.5 Nhwa Pharmaceutical Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Bipolar Disorder Mood Stabilizers Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Huahai Pharmaceutical
  68. 6.12.1 Huahai Pharmaceutical Company Information
  69. 6.12.2 Huahai Pharmaceutical Business Overview
  70. 6.12.3 Huahai Pharmaceutical Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Huahai Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio
  72. 6.12.5 Huahai Pharmaceutical Recent Developments
  73. 6.13 Hengrui Pharmaceuticals
  74. 6.13.1 Hengrui Pharmaceuticals Company Information
  75. 6.13.2 Hengrui Pharmaceuticals Business Overview
  76. 6.13.3 Hengrui Pharmaceuticals Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hengrui Pharmaceuticals Bipolar Disorder Mood Stabilizers Product Portfolio
  78. 6.13.5 Hengrui Pharmaceuticals Recent Developments
  79. 6.14 Glaxo Smith Kline
  80. 6.14.1 Glaxo Smith Kline Company Information
  81. 6.14.2 Glaxo Smith Kline Business Overview
  82. 6.14.3 Glaxo Smith Kline Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Glaxo Smith Kline Bipolar Disorder Mood Stabilizers Product Portfolio
  84. 6.14.5 Glaxo Smith Kline Recent Developments
  85. 6.15 Dongting Pharmaceutical
  86. 6.15.1 Dongting Pharmaceutical Company Information
  87. 6.15.2 Dongting Pharmaceutical Business Overview
  88. 6.15.3 Dongting Pharmaceutical Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dongting Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio
  90. 6.15.5 Dongting Pharmaceutical Recent Developments
  91. 6.16 Sihuan Pharma
  92. 6.16.1 Sihuan Pharma Company Information
  93. 6.16.2 Sihuan Pharma Business Overview
  94. 6.16.3 Sihuan Pharma Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sihuan Pharma Bipolar Disorder Mood Stabilizers Product Portfolio
  96. 6.16.5 Sihuan Pharma Recent Developments
  97. 6.17 AstraZeneca
  98. 6.17.1 AstraZeneca Company Information
  99. 6.17.2 AstraZeneca Business Overview
  100. 6.17.3 AstraZeneca Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 AstraZeneca Bipolar Disorder Mood Stabilizers Product Portfolio
  102. 6.17.5 AstraZeneca Recent Developments
  103. 6.18 Otsuka Pharmaceutical
  104. 6.18.1 Otsuka Pharmaceutical Company Information
  105. 6.18.2 Otsuka Pharmaceutical Business Overview
  106. 6.18.3 Otsuka Pharmaceutical Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Otsuka Pharmaceutical Bipolar Disorder Mood Stabilizers Product Portfolio
  108. 6.18.5 Otsuka Pharmaceutical Recent Developments
  109. 6.19 Lundbeck
  110. 6.19.1 Lundbeck Company Information
  111. 6.19.2 Lundbeck Business Overview
  112. 6.19.3 Lundbeck Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Lundbeck Bipolar Disorder Mood Stabilizers Product Portfolio
  114. 6.19.5 Lundbeck Recent Developments
  115. 6.20 Glenmark Pharmaceuticals
  116. 6.20.1 Glenmark Pharmaceuticals Company Information
  117. 6.20.2 Glenmark Pharmaceuticals Business Overview
  118. 6.20.3 Glenmark Pharmaceuticals Bipolar Disorder Mood Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Glenmark Pharmaceuticals Bipolar Disorder Mood Stabilizers Product Portfolio
  120. 6.20.5 Glenmark Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Bipolar Disorder Mood Stabilizers Sales by Country
  2. 7.1.1 North America Bipolar Disorder Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026)
  4. 7.1.3 North America Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bipolar Disorder Mood Stabilizers Market Size by Country
  6. 7.2.1 North America Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026)
  8. 7.2.3 North America Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bipolar Disorder Mood Stabilizers Sales by Country
  2. 8.1.1 Europe Bipolar Disorder Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026)
  4. 8.1.3 Europe Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bipolar Disorder Mood Stabilizers Market Size by Country
  6. 8.2.1 Europe Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bipolar Disorder Mood Stabilizers Sales by Country
  2. 9.1.1 Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size by Country
  6. 9.2.1 Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bipolar Disorder Mood Stabilizers Sales by Country
  2. 10.1.1 South America Bipolar Disorder Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026)
  4. 10.1.3 South America Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bipolar Disorder Mood Stabilizers Market Size by Country
  6. 10.2.1 South America Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026)
  8. 10.2.3 South America Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bipolar Disorder Mood Stabilizers Sales by Country
  2. 11.1.1 Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bipolar Disorder Mood Stabilizers Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bipolar Disorder Mood Stabilizers Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size by Country
  6. 11.2.1 Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bipolar Disorder Mood Stabilizers Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bipolar Disorder Mood Stabilizers Value Chain Analysis
  2. 12.1.1 Bipolar Disorder Mood Stabilizers Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bipolar Disorder Mood Stabilizers Production Mode & Process
  7. 12.2 Bipolar Disorder Mood Stabilizers Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bipolar Disorder Mood Stabilizers Distributors
  10. 12.2.3 Bipolar Disorder Mood Stabilizers Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst